Pneumococcal Vaccine Study
Coming Soon!
Pneumococcal Vaccine Study
for Adults 18-49
You can help advance Pneumococcal vaccine research!
Introducing a pneumococcal vaccine clinical trial for healthy volunteers 18 through 49 years of age. By participating in this clinical trial, you can help us learn if a study vaccine is safe and provides protection against more strains of pneumococcal bacteria than the currently available vaccine (Prevnar 20®).
About the Pneumococcal Vaccine Study
The Pneumococcal Vaccine Study is a clinical trial for vaccine(PG4) to determine if it is safe and provides protection against more strains of pneumococcal bacteria than our currently available vaccine (Prevnar 20®).
You may be able to take part in the Pneumococcal Vaccine Study if you:
- Are aged 18-49
- Are generally healthy or have stable chronic conditions
- Have not received pneumococcal vaccine after the age of 5 years old
- Do not have a history of a severe reaction associated with any vaccine
- There may be other requirements that can be discussed with the study team
You may receive compensation up to $525 for inconvenience and travel.
If you are interested in participating, the study doctor and staff will review additional eligibility criteria with you and answer any questions you may have.
Pneumococcal Vaccine Study
for Adults 18-49
Call (561) 689-0606 or
Complete The Questionnaire Below
To Submit Your Information For This Study
Taking part in this clinical trial may help improve vaccine protection not only for you, but also others in the future. Your participation could make a difference.
Call (561) 689-0606 or
Complete The Questionnaire Below
To Submit Your Information For This Study
Diversity in Clinical Research Studies
People may experience the vaccine differently based on their race, ethnicity, gender, age, and background. Our Pneumococcal Vaccine Study is committed to including a diverse range of participants. We aim to ensure that people from various communities are represented, helping us understand how the investigational medication works across different groups. By prioritizing diversity, we can gain a more complete picture of its effectiveness, ultimately leading to better treatment options for everyone. Your unique experience matters in making a difference!
Why are clinical studies important?
Clinical trials are the best way to find out if new treatments or vaccines work and how safe they are. If clinical trials show that a new treatment works and is safe, then it can be approved to be used by the people who need it.
Not all clinical trials test a new treatment or vaccine. “Observational” studies collect information about people’s health during their normal care. This helps researchers learn more about specific health issues.
What is a clinical research study?
A clinical research study is a medical study that helps to answer important questions about an investigational medication or vaccine. such as:
- Is it effective?
- What amount. or dose. may work best?
- How safe is it?
- Are there side effects?
All medications and vaccines must be tested in clinical research studies before they can be approved for use. Without people taking part in these studies, we would have no new medications or vaccines
Clinical research studies should include groups of people who may be at higher risk based on their age, sex. and race/ethnicity.
An Institutional Review Board (IRB)/Ethics Committee (EC), which protects the rights, safety, and wellbeing of the participants has approved this study.
Call (561) 689-0606 or
Complete The Questionnaire Below
To Submit Your Information For This Study
